News

Minaris Regenerative Medicine is proud to share current and past news and announcements from its over twenty years of experience. Please see below for our press releases and announcements.

    *This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services) and apceth Biopharma GmBH are now operating under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.
    October 19, 2017

    DCPrime and apceth Biopharma GmbH Announce Manufacturing Partnership

                                                                         
    October 19, 2017

    PCT Establishes Global Contract Development and Manufacturing Services Platform with Opening of Yokohama, Japan Facility

    Yokohama, Japan, October 19, 2017: Hitachi Chemical Co., Ltd. (HCC), a global service provider for the cell therapy industry through its PCT development and manufacturing service platform, today announced the completion of construction and opening of its Yokohama, Japan facility on October 11. This facility, as well as the existing two U.S. PCT facilities, will share the same global PCT service ...
    October 10, 2017

    PCT GMP Manufacturing Infrastructure and Cleanroom Capacity Expands to Support Clients through Commercial Stage

    Allendale, NJ, USA, October 10, 2017   Today, Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS), a global service provider for the cell therapy industry through its PCT development and manufacturing platform, announced the planned expansion of its PCT service platform through the addition of GMP manufacturing infrastructure and cleanroom capacity in Allendale, NJ. The expansion ...
    All Posts

    Stay up to date on the latest cell therapy industry insights
    © 2022 Minaris Regenerative Medicine   |  Privacy Policy   |  Imprint